GGrantIndex
← Leaderboards

Jonathan D Powell

Johns Hopkins University

$15,512,358
Attributed
$15,958,502
Total exposure
11
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY200524
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$15,958,502 · 11

By mechanism

R01$11,059,996 · 6
P41$1,591,494 · 1
U54$1,561,632 · 2
P01$1,478,580 · 1
K22$266,800 · 1

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “T-Lymphocyte

Research focus

T-LymphocyteMediatingT-Cell ActivationCellsGenerationsCell PhysiologyTumorAntigensAnergySignal TransductionProteinsImmune ResponsePathway InteractionsIn VivoImmunityInsightPlayProgramsBasePhenotypePreventAutoimmunityIn VitroMetabolism

Grant awards (48)

Project 2: Interrogating immuno-metabolic programs using a novel Flow Cytometry based  assay to reveal novel T cell subsets in SARS-CoV-2 infected patients$126,657
U54 · FY2024 · CA · contact PI
TR&D3: Metabolic Programming$314,020
P41 · FY2023 · EB · contact PI
Project 2: Interrogating immuno-metabolic programs using a novel Flow Cytometry based  assay to reveal novel T cell subsets in SARS-CoV-2 infected patients$451,729
U54 · FY2022 · CA · contact PI
TR&D3: Metabolic Programming$318,933
P41 · FY2022 · EB · contact PI
TR&D3: Metabolic Programming$315,763
P41 · FY2021 · EB · contact PI
Project 2: Interrogating immuno-metabolic programs using a novel Flow Cytometry based  assay to reveal novel T cell subsets in SARS-CoV-2 infected patients$983,246
U54 · FY2020 · CA · contact PI
Targeting Tumor Metabolism as a Means of Enhancing Immunotherapy$374,578
R01 · FY2020 · CA · contact PI
TR&D3: Metabolic Programming$322,208
P41 · FY2020 · EB · contact PI
Cell-targeted glutamine antagonists as a novel therapy for lymphoma$439,350
R01 · FY2019 · CA
A central role for mTOR in Determining T Cell Activation versus Tolerance$405,000
R01 · FY2019 · AI · contact PI
Targeting Tumor Metabolism as a Means of Enhancing Immunotherapy$374,578
R01 · FY2019 · CA · contact PI
TR&D3: Metabolic Programming$320,570
P41 · FY2019 · EB · contact PI
Cell-targeted glutamine antagonists as a novel therapy for lymphoma$452,939
R01 · FY2018 · CA
A central role for mTOR in Determining T Cell Activation versus Tolerance$405,000
R01 · FY2018 · AI · contact PI
A central role for mTOR in Determining T Cell Activation versus Tolerance$405,000
R01 · FY2017 · AI · contact PI
A central role for mTOR in Determining T Cell Activation versus Tolerance$405,000
R01 · FY2016 · AI · contact PI
A central role for mTOR in Determining T Cell Activation versus Tolerance$405,000
R01 · FY2015 · AI · contact PI
Transplantation tolerance and immune function following mTOR inhibition.$381,546
R01 · FY2013 · AI · contact PI
A central role for mTOR in Determining T Cell Activation versus Tolerance$377,731
R01 · FY2013 · AI · contact PI
Egr-2/3 and NAB2 in T Cell Anergy and Activation$257,775
R01 · FY2013 · CA · contact PI
Transplantation tolerance and immune function following mTOR inhibition.$405,900
R01 · FY2012 · AI · contact PI
A central role for mTOR in Determining T Cell Activation versus Tolerance$401,841
R01 · FY2012 · AI · contact PI
Sprouty1 is a novel negative regulator of T cell activation$298,453
P01 · FY2012 · AI · contact PI
Egr-2/3 and NAB2 in T Cell Anergy and Activation$274,229
R01 · FY2012 · CA · contact PI
Transplantation tolerance and immune function following mTOR inhibition.$405,900
R01 · FY2011 · AI · contact PI
A central role for mTOR in Determining T Cell Activation versus Tolerance$401,841
R01 · FY2011 · AI · contact PI
Sprouty1 is a novel negative regulator of T cell activation$296,477
P01 · FY2011 · AI · contact PI
Egr-2/3 and NAB2 in T Cell Anergy and Activation$266,003
R01 · FY2011 · CA · contact PI
Transplantation tolerance and immune function following mTOR inhibition.$410,000
R01 · FY2010 · AI · contact PI
A central role for mTOR in Determining T Cell Activation versus Tolerance$405,900
R01 · FY2010 · AI · contact PI
Sprouty1 is a novel negative regulator of T cell activation$296,897
P01 · FY2010 · AI · contact PI
Egr-2/3 and NAB2 in T Cell Anergy and Activation$274,229
R01 · FY2010 · CA · contact PI
A2a receptor engagement promotes T cell tolerance$254,392
R01 · FY2010 · CA · contact PI
A central role for mTOR in Determining T Cell Activation versus Tolerance$410,000
R01 · FY2009 · AI · contact PI
Sprouty1 is a novel negative regulator of T cell activation$291,226
P01 · FY2009 · AI · contact PI
Egr-2/3 and NAB2 in T Cell Anergy and Activation$274,229
R01 · FY2009 · CA · contact PI
A2a receptor engagement promotes T cell tolerance$273,392
R01 · FY2009 · CA · contact PI
Sprouty1 is a novel negative regulatorof T cell activation$295,527
P01 · FY2008 · AI · contact PI
A2a receptor engagement promotes T cell tolerance$254,392
R01 · FY2008 · CA · contact PI
A2a receptor engagement promotes T cell tolerance$254,392
R01 · FY2007 · CA · contact PI
EGR-2/3 and NAB2 in T Cell Anergy and Activation$80,558
R01 · FY2007 · CA · contact PI
EGR-2/3 and NAB2 in T Cell Anergy and Activation$265,431
R01 · FY2006 · CA · contact PI
A2a receptor engagement promotes T cell tolerance$261,258
R01 · FY2006 · CA · contact PI
EGR-2/3 and NAB2 in T Cell Anergy and Activation$271,819
R01 · FY2005 · CA
EGR-2/3 and NAB2 in T Cell Anergy and Activation$271,819
R01 · FY2004 · CA
EGR-2/3 and NAB2 in T Cell Anergy and Activation$258,974
R01 · FY2003 · CA
INDUCTION AND MAINTENANCE OF T CELL ANERGY$108,000
K22 · FY2002 · AI
INDUCTION AND MAINTENANCE OF T CELL ANERGY$158,800
K22 · FY2001 · AI